Activist investor Carl Icahn will not push for director nominations at Biogen's (Nasdaq: BIIB) annual shareholder meeting this year ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE